Homozygous Familial Hypercholesterolemia Market is segmented By Drug Type (PCSK9 Inhibitors, Mipomersen, Lomitapide), By Route of Administration (Subcutaneous, Oral), By ....
The major players operating in the Homozygous Familial Hypercholesterolemia Market include Amgen Inc., Sanofi S.A., Regeneron Pharmaceuticals, Inc., Novartis AG, and Ionis Pharmaceuticals, Inc.
Homozygous Familial Hypercholesterolemia Market